Coherus Biosciences (CHRS) PT Lowered to $27 at Truist Securities

February 26, 2021 7:34 AM EST Send to a Friend

Truist Securities lowered its price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Coherus Biosciences (CHRS) PT Lowered to $27 at Truist Securities

Member Login

Free News Feed